BENJAMIN GIER: Open Payments
NPI 1437528478 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,047 in 62 payments from 13 companies in 2025. Trend: 2023 $1,568 · 2024 $1,274 · 2025 $2,047
Food & beverage: $1,901Education: $146
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $637 |
| ABBVIE INC. | 13 | $360 |
| Lilly USA, LLC | 9 | $229 |
| Organon LLC | 5 | $201 |
| GENZYME CORPORATION | 1 | $123 |
| Galderma Laboratories, L.P. | 6 | $102 |
| Amgen Inc. | 5 | $94 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $83 |
| UCB, Inc. | 2 | $64 |
| Arcutis Biotherapeutics, Inc. | 3 | $57 |
Products named: TREMFYA, TALTZ, SKYRIZI, VTAMA, RINVOQ, DUPIXENT, OTEZLA, Winlevi.
Industry payments across MI — which companies pay providers there.
